Oval instruments ease bimanual cataract surgery

Article

Using oval choppers and needles during bimanual cataract surgery spares energy and maintains anterior chamber stability.

Using oval choppers and needles during bimanual cataract surgery spares energy and maintains anterior chamber stability, according to Fernando Araujo-Gomes from the Clinica de Santo Antonio, Amadora, Portugal.

According to Dr Gomes, the advantage of oval-designed instruments is related to their ability to form a closed, energy-sparing, system thus minimising fluid loss and pressure.

A total of 750 consecutive cataracts, both soft and hard, underwent surgery using oval choppers and needles. Depending on the hardness of cataract, 20-gauge (1.4 mm opening) or 21-gauge (1.2 mm opening) were used.

All surgeries were straightforward, quick and effective and maintained good anterior chamber stability.

According to Dr Gomes, there is no need to avoid bimanual cataract surgery, particularly because there are no other types of surgery that will allow surgeons to create a 1.4 mm incision whilst employing a separate irrigation line, which he finds beneficial.

Related Videos
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
At this year's ARVO meeting, Paolo Silva, MD, presented data on Protocol AA on behalf of the DRCR Retina Network
© 2024 MJH Life Sciences

All rights reserved.